These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28477461)

  • 1. Recent progress in the understanding of complement activation and its role in tumor growth and anti-tumor therapy.
    Liu XY; Wang XY; Li RY; Jia SC; Sun P; Zhao M; Fang C
    Biomed Pharmacother; 2017 Jul; 91():446-456. PubMed ID: 28477461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichotomy of complement system: Tumorigenesis or destruction.
    Sinha A; Singh V; Tandon R; Mohan Srivastava L
    Immunol Lett; 2020 Jul; 223():89-96. PubMed ID: 32333965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement as a Biological Tool to Control Tumor Growth.
    Macor P; Capolla S; Tedesco F
    Front Immunol; 2018; 9():2203. PubMed ID: 30319647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the complement system in cancer.
    Afshar-Kharghan V
    J Clin Invest; 2017 Mar; 127(3):780-789. PubMed ID: 28248200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement system in cancer: Ambivalence between tumour destruction and promotion.
    Mamidi S; Höne S; Kirschfink M
    Immunobiology; 2017 Jan; 222(1):45-54. PubMed ID: 26686908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
    Meyer S; Leusen JH; Boross P
    MAbs; 2014; 6(5):1133-44. PubMed ID: 25517299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting innate immune pathways in cancer immunotherapy: state of the art.
    Mastellos DC
    J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement inhibition in cancer therapy.
    Pio R; Ajona D; Lambris JD
    Semin Immunol; 2013 Feb; 25(1):54-64. PubMed ID: 23706991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG; Spendlove I
    Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement in monoclonal antibody therapy of cancer.
    Rogers LM; Veeramani S; Weiner GJ
    Immunol Res; 2014 Aug; 59(1-3):203-10. PubMed ID: 24906530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and the complement cascade.
    Rutkowski MJ; Sughrue ME; Kane AJ; Mills SA; Parsa AT
    Mol Cancer Res; 2010 Nov; 8(11):1453-65. PubMed ID: 20870736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane attack complex of complement in dermatitis herpetiformis.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics.
    Melis JP; Strumane K; Ruuls SR; Beurskens FJ; Schuurman J; Parren PW
    Mol Immunol; 2015 Oct; 67(2 Pt A):117-30. PubMed ID: 25697848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement modulation in solid-organ transplantation.
    Touzot M; Obada EN; Beaudreuil S; François H; Durrbach A
    Transplant Rev (Orlando); 2014 Jul; 28(3):119-25. PubMed ID: 24996770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of complement in tumor growth.
    Pio R; Corrales L; Lambris JD
    Adv Exp Med Biol; 2014; 772():229-62. PubMed ID: 24272362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer exploiting complement: a clue or an exception?
    Loveland BE; Cebon J
    Nat Immunol; 2008 Nov; 9(11):1205-6. PubMed ID: 18936777
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement as effector system in cancer immunotherapy.
    Macor P; Tedesco F
    Immunol Lett; 2007 Jul; 111(1):6-13. PubMed ID: 17572509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Bothrops atrox venom and two isolated toxins on the human complement system: Modulation of pathways and generation of anaphylatoxins.
    Menaldo DL; Bernardes CP; Jacob-Ferreira AL; Nogueira-Santos CG; Casare-Ogasawara TM; Pereira-Crott LS; Sampaio SV
    Mol Immunol; 2016 Dec; 80():91-100. PubMed ID: 27846429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of complement in tumour growth and metastasis (Review).
    Stover C
    Int J Mol Med; 2010 Mar; 25(3):307-13. PubMed ID: 20127033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.